TABLE OF CONTENTS

Volume 29, Issue 6 (June 2004)

Top

Perspectives

Dopamine Dysfunction in Borderline Personality Disorder: A Hypothesis FREE

Robert O Friedel

Neuropsychopharmacology 29: 1029-1039; advance online publication, March 24, 2004; doi:10.1038/sj.npp.1300424

A Model of Antipsychotic Action in Conditioned Avoidance: A Computational Approach FREE

Andrew Smith, Ming Li, Sue Becker and Shitij Kapur

Neuropsychopharmacology 29: 1040-1049; advance online publication, March 3, 2004; doi:10.1038/sj.npp.1300414

Top

Original Articles

Preclinical Research

Genetic and Pharmacological Evidence of a Role for GABAB Receptors in the Modulation of Anxiety- and Antidepressant-Like Behavior FREE

Cedric Mombereau, Klemens Kaupmann, Wolfgang Froestl, Gilles Sansig, Herman van der Putten and John F Cryan

Neuropsychopharmacology 29: 1050-1062; advance online publication, March 24, 2004; doi:10.1038/sj.npp.1300413

Effects of Chronic Haloperidol and Clozapine Treatment on Neurogenesis in the Adult Rat Hippocampus FREE

Nader D Halim, Cynthia Shannon Weickert, Benjamin W McClintock, Daniel R Weinberger and Barbara K Lipska

Neuropsychopharmacology 29: 1063-1069; advance online publication, March 10, 2004; doi:10.1038/sj.npp.1300422

Identification of Genes Regulated by Memantine and MK-801 in Adult Rat Brain by cDNA Microarray Analysis FREE

Markéta Marvanová, Merja Lakso and Garry Wong

Neuropsychopharmacology 29: 1070-1079; advance online publication, February 18, 2004; doi:10.1038/sj.npp.1300398

Spatial Memory Deficits Induced by Perinatal Treatment of Rats with PCP and Reversal Effect of D-Serine FREE

Janne Damm Andersen and Bruno Pouzet

Neuropsychopharmacology 29: 1080-1090; advance online publication, February 18, 2004; doi:10.1038/sj.npp.1300394

RGSZ1 and GAIP Regulate mu- but Not delta-Opioid Receptors in Mouse CNS: Role in Tachyphylaxis and Acute Tolerance FREE

Javier Garzón, María Rodríguez-Muñoz, Almudena López-Fando, Antonio García-España and Pilar Sánchez-Blázquez

Neuropsychopharmacology 29: 1091-1104; advance online publication, March 3, 2004; doi:10.1038/sj.npp.1300408

Total Sleep Deprivation Decreases Immobility In The Forced-Swim Test FREE

Faustino Lopez-Rodriguez, Joseph Kim and Russell E Poland

Neuropsychopharmacology 29: 1105-1111; advance online publication, February 18, 2004; doi:10.1038/sj.npp.1300406

Corticotropin-Releasing Hormone Antagonists, Astressin B and Antalarmin: Differing Profiles of Activity in Rhesus Monkeys FREE

Jillian H Broadbear, Gail Winger, Jean E Rivier, Kenner C Rice and James H Woods

Neuropsychopharmacology 29: 1112-1121; advance online publication, March 3, 2004; doi:10.1038/sj.npp.1300410

Modulation of Anxiety-Like Behavior and Morphine Dependence in CREB-Deficient Mice FREE

Olga Valverde, Theo Mantamadiotis, María Torrecilla, Luisa Ugedo, Joseba Pineda, Susanne Bleckmann, Peter Gass, Oliver Kretz, Jennifer M Mitchell, Günther Schütz and Rafael Maldonado

Neuropsychopharmacology 29: 1122-1133; advance online publication, March 17, 2004; doi:10.1038/sj.npp.1300416

Experimental Parkinsonism Alters Anandamide Precursor Synthesis, and Functional Deficits are Improved by AM404: A Modulator of Endocannabinoid Function FREE

Emilio Fernandez-Espejo, Isabel Caraballo, Fernando Rodriguez de Fonseca, Belen Ferrer, Fadwa El Banoua, Juan A Flores and Beatriz Galan-Rodriguez

Neuropsychopharmacology 29: 1134-1142; advance online publication, March 10, 2004; doi:10.1038/sj.npp.1300407

Clinical Research

Altered 5-HT2A Receptor Binding after Recovery from Bulimia-Type Anorexia Nervosa: Relationships to Harm Avoidance and Drive for Thinness FREE

Ursula F Bailer, Julie C Price, Carolyn C Meltzer, Chester A Mathis, Guido K Frank, Lisa Weissfeld, Claire W McConaha, Shannan E Henry, Sarah Brooks-Achenbach, Nicole C Barbarich and Walter H Kaye

Neuropsychopharmacology 29: 1143-1155; advance online publication, March 31, 2004; doi:10.1038/sj.npp.1300430

Effect of Ethanol on Hypothalamic–Pituitary–Adrenal System Response to Psychosocial Stress in Sons of Alcohol-Dependent Fathers FREE

Ulrich Zimmermann, Konstanze Spring, Sabine Ruth Kunz-Ebrecht, Manfred Uhr, Hans-Ulrich Wittchen and Florian Holsboer

Neuropsychopharmacology 29: 1156-1165; advance online publication, April 21, 2004; doi:10.1038/sj.npp.1300395

Addition of the alpha2-Antagonist Yohimbine to Fluoxetine: Effects on Rate of Antidepressant Response FREE

Gerard Sanacora, Robert M Berman, Angela Cappiello, Dan A Oren, Akira Kugaya, Nianjun Liu, Ralitza Gueorguieva, Donna Fasula and Dennis S Charney

Neuropsychopharmacology 29: 1166-1171; advance online publication, March 10, 2004; doi:10.1038/sj.npp.1300418

Mechanisms of Action Underlying the Effect of Repetitive Transcranial Magnetic Stimulation on Mood: Behavioral and Brain Imaging Studies FREE

Jennifer Barrett, Valeria Della-Maggiore, Philippe A Chouinard and Tomás caron Paus

Neuropsychopharmacology 29: 1172-1189; advance online publication, March 17, 2004; doi:10.1038/sj.npp.1300411

Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior FREE

Diana Martinez, Allegra Broft, Richard W Foltin, Mark Slifstein, Dah-Ren Hwang, Yiyun Huang, Audrey Perez, W Gordon Frankel, Thomas Cooper, Herbert D Kleber, Marian W Fischman and Marc Laruelle

Neuropsychopharmacology 29: 1190-1202; advance online publication, March 10, 2004; doi:10.1038/sj.npp.1300420

Acute Ketamine Administration Alters the Brain Responses to Executive Demands in a Verbal Working Memory Task: an fMRI Study FREE

R A E Honey, G D Honey, C O'Loughlin, S R Sharar, D Kumaran, E T Bullmore, D K Menon, T Donovan, V C Lupson, R Bisbrown-Chippendale and P C Fletcher

Neuropsychopharmacology 29: 1203-1214; advance online publication, April 21, 2004; doi:10.1038/sj.npp.1300438

Top

Obituary

J Christian Gillin, 1938–2003 FREE

Lewis L Judd The ACNP Group

Neuropsychopharmacology 29: 1215-1216; doi:10.1038/sj.npp.1300359

Top

Letter to the Editor

Correspondence

Valproic Acid Induces Manifestations of Simultaneous Dopamine Enhancement and Reduction in Schizophrenia FREE

Lina M Lopez, Adel A Wassef, Melissa S Molloy and Nina G Williams

Neuropsychopharmacology 29: 1217; doi:10.1038/sj.npp.1300461

Top

Correspondence

Reply to Lopez et al

Reply: Valproate Treatment in Schizophrenia: Interaction of GABA with Dopamine? FREE

Georg Winterer, Ulrich Schmitt and Lutz G Schmidt

Neuropsychopharmacology 29: 1218-1220; doi:10.1038/sj.npp.1300462

Extra navigation

.
ADVERTISEMENT